Gunderson Dettmer advised Photys Therapeutics on the deal. Photys Therapeutics, a developer of phosphorylation-inducing chimeric small molecule (PHICS) medicines, announced its $75 million Series A financing...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Carbon Biosciences on the deal. Carbon Biosciences, a developer of novel parvovirus-derived gene therapies, announced its emergence from stealth mode and the closing of...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Elephant on the deal. Elephant led the $27.7 million Series A financing of Triple Whale, an all-in-one operating system for Shopify. Triple Whale’s platform...
You must be a Standard 1 Year member to access this content.
Fenwick and Marval, O’Farrell & Mairal represented CLEAR on the deal. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and Mitrani, Caballero & Ruiz Moreno advised Whyline....
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Well on the deal. Well, a digital health improvement platform, announced its $70 million Series B financing led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of...
You must be a Standard 1 Year member to access this content.
